The Expression of

CCAT2 GHET1 Lung cancer PANDA UCA1 lncRNAs

Journal

Reports of biochemistry & molecular biology
ISSN: 2322-3480
Titre abrégé: Rep Biochem Mol Biol
Pays: Iran
ID NLM: 101637937

Informations de publication

Date de publication:
Apr 2019
Historique:
entrez: 24 7 2019
pubmed: 25 7 2019
medline: 25 7 2019
Statut: ppublish

Résumé

Long non-coding RNAs (lncRNAs) have been considered to be prospective biomarkers for diagnosing lung cancer due to the fundamental roles they hold in the regulating several cancer-related pathways. Using the quantitative real-time polymerase chain reaction method, we evaluated the expression of No significant differences were found in the expression of lncRNAs within the tumoral and non-tumoral tissue samples. Bayesian Multilevel analysis showed no association between the expression of lncRNAs and the patient's tumor node metastasis (TNM) stage following adjustments for age. Spearman correlation analysis revealed an inverse correlation between the expression of Despite the findings supporting a role for the lncRNAs,

Sections du résumé

BACKGROUND BACKGROUND
Long non-coding RNAs (lncRNAs) have been considered to be prospective biomarkers for diagnosing lung cancer due to the fundamental roles they hold in the regulating several cancer-related pathways.
METHODS METHODS
Using the quantitative real-time polymerase chain reaction method, we evaluated the expression of
RESULTS RESULTS
No significant differences were found in the expression of lncRNAs within the tumoral and non-tumoral tissue samples. Bayesian Multilevel analysis showed no association between the expression of lncRNAs and the patient's tumor node metastasis (TNM) stage following adjustments for age. Spearman correlation analysis revealed an inverse correlation between the expression of
CONCLUSION CONCLUSIONS
Despite the findings supporting a role for the lncRNAs,

Identifiants

pubmed: 31334286
pmc: PMC6590943

Types de publication

Journal Article

Langues

eng

Pagination

36-41

Références

Aquat Toxicol. 2012 Apr;110-111:84-90
pubmed: 22277249
Tumour Biol. 2014 Jun;35(6):5375-80
pubmed: 24504682
J Steroid Biochem Mol Biol. 2014 May;141:160-70
pubmed: 24533973
Toxicol Appl Pharmacol. 2015 Jan 1;282(1):9-19
pubmed: 25447409
Inflamm Res. 2015 Feb;64(2):119-26
pubmed: 25542208
Cell Death Dis. 2015 Feb 26;6:e1665
pubmed: 25719249
Int J Clin Exp Med. 2015 Jul 15;8(7):11824-30
pubmed: 26380024
Toxicol Appl Pharmacol. 2015 Dec 1;289(2):276-85
pubmed: 26415832
Respir Med. 2016 Jan;110:12-9
pubmed: 26603340
Cancer Lett. 2016 Feb 1;371(1):99-106
pubmed: 26655272
Biomed Pharmacother. 2017 Mar;87:692-697
pubmed: 28088736
Cancer Biomark. 2018 Feb 14;21(3):557-563
pubmed: 29286919
Sci Rep. 2018 Feb 2;8(1):2202
pubmed: 29396444
Noncoding RNA. 2018 Apr 18;4(2):null
pubmed: 29670042

Auteurs

Farbod Esfandi (F)

Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
GenIran Lab, Tashkhis Gene Pajohesh, Tehran, Iran.

Hamid Fallah (H)

Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Shahram Arsang-Jang (S)

Clinical Research Development Center (CRDU), Qom University of Medical Sciences, Qom, Iran.

Mohammad Taheri (M)

Urogenital Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Soudeh Ghafouri-Fard (S)

Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Classifications MeSH